Shire PLC
15 Minute Delayed Share Price
Glossary
Go to Portfolio
|
Current
|
Chg
|
% Chg |
Open |
High |
Low |
Volume |
| 1,159.00 |
+24.00
|
2.11%
|
1,139.00 |
1,173.00 |
1,138.32 |
1.20m |
Share Price Chart
Broker Recommendation (9 Brokers)
STRONG SELL
STRONG BUY
HOLD
Company Background
| Sector |
Health
|
| Activities |
Focuses on attention deficit and hyperactivity disorder, human genetic therapies and gastrointestinal diseases |
| TIDM |
SHP |
| Index |
FTSE 100, FTSE 350, Eurotop 300, S&P Europe 350, FTSE All Share, FTSE Techmark All Share, FTSE techMARK 100 |
| Listed |
LSE - Full |
Outlook
(30/10/2009)
3QT: ceo - "Shire continues to deliver excellent growth"
Latest Results
| 3rd Quarter |
30/9/2008 |
30/9/2009 |
| Turnover |
£m |
1268.21 |
1322.16 |
| Pre-tax Profit |
£m |
43.45 |
241.5 |
| EPS (Norm Dil.) |
p |
8.71 |
32.63 |
| Dividend |
p |
0 |
5.47 |
| Notes |
Figures from 2003 in accordance with IFRS. USD to GBP, 2004: 1.93370, 2005: 1.72030, 2006: 1.96330, 2007: 2.0077, 2008: 1.4582. Information taken from admission document dated 16 April 2008 |
Investment Ratios
| |
Co. |
FTSE Sector |
Market |
| PER (pr) |
x |
17.63 |
10.30 |
12.72 |
| Dividend Yield (pr) |
% |
0.58 |
4.85 |
3.92 |
| PEG (pr) |
f |
1.09 |
0.93 |
0.23 |
| ROCE |
% |
83.12 |
52.99 |
-7.72 |
| Operating Margin |
% |
16.71 |
16.34 |
10.26 |
| EPS Growth (pr) |
% |
16.14 |
3.94 |
12.50 |
| EV/EBITDA |
x |
12.97 |
7.41 |
6.60 |
| Net Gearing |
% |
69.00 |
94.90 |
160.37 |
| Net Tangible Asset Value PS |
p |
-107.42 |
-1.06 |
1.35 |
| Price to Tangible Book Value (PTBV) |
x |
-10.79 |
-8.24 |
0.69 |
| Price to Cashflow (PCF) |
x |
11.61 |
8.74 |
9.33 |
| Price to Sales Ratio (PSR) |
x |
3.03 |
2.66 |
2.08 |
Data provided by
Morningstar.
© Copyright 2009 Morningstar.
All rights reserved. Please read our
Terms of Use
and
Privacy Policy.